Skip to main content

Table 1 Demographic and clinical characteristics of paediatric patients with MRSA infections

From: Emergence and spread of a new community-genotype methicillin-resistant Staphylococcus aureus clone in Colombia

Demographic data and clinical characteristics

All subjects (n = 19)

n (%)

Age (years) (range)

8.3 (0.17–14)

Age distribution

 Newborn

0 (0.0)

 Infants

1 (5.3)

 Pre-school age

4 (21.1)

 School age

7 (36.8)

 Adolescents

7 (36.8)

Male sex, %

12 (63.0)

Year of recovery (time in months)a

 2009 (3)

1 (5.3)

 2010 (12)

2 (10.5)

 2011 (12)

9 (47.4)

 2012 (6)

7 (36.8)

Admission Site

 Emergency room

19 (100.0)

Clinical diagnosis

 SSTIb

10 (43.8)

 Osteoarticular infection

5 (26.0)

 Pneumonia

1 (5.6)

 Septic Shock

3 (2.5)

Onset time of symptoms (mean, SDc), days

17.4 (20.0)

Hospital managementd

 Hospitalized- drainage

15 (69.1)

 PICU

4 (24.1)

Empirical antimicrobial therapye

 CLI

13 (68.4)

 OXA

2 (10.5)

 CLI/RIF

2 (10.5)

 RIF

1 (5.3)

 CLI/RIF/VAN

1 (5.3)

Definitive antimicrobial therapye

 SXT

11 (57.9)

 CLI/RIF

3 (15.8)

 OXA

1 (5.3)

 RIF

1 (5.3)

 CLI

1 (5.3)

 CLI/RIF/VAN

1 (5.3)

 VAN/LZD/SXT

1 (5.3)

Clinical outcome

 Improvement

19 (100.0)

  1. aThe collection time of the isolates was between October 2009 and June 2012
  2. b SSTI Skin and soft tissue infection
  3. c SD standard deviation
  4. d PICU paediatric intensive care unit
  5. e CLI clindamycin, OXA oxacillin, RIF rifampicin, SXT trimethoprim-sulfamethoxazole, VAN vancomycin, LZD linezolid